We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$106M
(-9.2%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-16.63%
Top 10 Holdings %
Top 10 Hldgs %
5.73%
Holding
1,387
New
364
Increased
246
Reduced
349
Closed
422
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$5.05M |
| 2 |
Century Aluminum
CENX
|
+$4.6M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$4.54M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$4.51M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OneSpan
OSPN
|
+$7.67M |
| 2 |
Lattice Semiconductor
LSCC
|
+$7.09M |
| 3 |
Mercury Insurance
MCY
|
+$5.38M |
| 4 |
Omnicell
OMCL
|
+$5.15M |
| 5 |
Maximus
MMS
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.11% |
| 2 | Technology | 14.11% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Murphy USA
MUSA
$11.3B
| $2.18M | 0.21% |
31,626
+3,067
| +11% | +$182K |
|
127
Methode Electronics
MEI
$543M
| $2.17M | 0.21% |
59,323
-117,002
| -66% | -$4.39M |
|
|
SEM
128
DELISTED
Select Medical
SEM
| $2.16M | 0.21% |
278,528
-351,298
| -56% | -$2.56M |
|
|
NTUS
129
DELISTED
Natus Medical Inc
NTUS
| $2.16M | 0.21% |
59,862
-109,227
| -65% | -$3.67M |
|
130
Advanced Micro Devices
AMD
$851B
| $2.1M | 0.2% |
+786,801
| New | +$2.16M |
|
131
Charles River Laboratories
CRL
$10.9B
| $2.1M | 0.2% |
32,994
-32,173
| -49% | -$2.02M |
|
|
MCF
132
DELISTED
Contango Oil & Gas Co.
MCF
| $2.09M | 0.2% |
71,425
+50,909
| +248% | +$1.71M |
|
133
First Horizon
FHN
$12.1B
| $2.07M | 0.2% |
152,266
+103,964
| +215% | +$1.32M |
|
134
Phibro Animal Health
PAHC
$1.38B
| $2.07M | 0.2% |
+65,507
| New | +$1.81M |
|
|
HNH
135
DELISTED
Handy & Harman Holdings Ltd.
HNH
| $2.06M | 0.2% |
+44,638
| New | +$1.62M |
|
|
RDUS
136
DELISTED
Radius Recycling
RDUS
| $2.05M | 0.2% |
90,803
+80,682
| +797% | +$1.85M |
|
|
PSEM
137
DELISTED
PERICOM SEMICONDUCTOR CP
PSEM
| $2.04M | 0.19% |
150,846
+112,782
| +296% | +$1.32M |
|
|
CDI
138
DELISTED
CDI Corp.
CDI
| $2.04M | 0.19% |
115,069
+32,432
| +39% | +$543K |
|
139
Marchex
MCHX
$79.7M
| $2.02M | 0.19% |
+440,099
| New | +$1.74M |
|
|
XNPT
140
DELISTED
XENOPORT, INC.
XNPT
| $2.01M | 0.19% |
229,234
+116,072
| +103% | +$852K |
|
|
FPRX
141
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2M | 0.19% |
74,239
+54,686
| +280% | +$941K |
|
142
BlackRock Enhanced Global Dividend Trust
BOE
$662M
| $2M | 0.19% |
+152,286
| New | +$2.09M |
|
143
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
| $2M | 0.19% |
99,429
+36,652
| +58% | +$736K |
|
144
Digital Realty Trust
DLR
$73.7B
| $1.98M | 0.19% |
29,906
+3,597
| +14% | +$240K |
|
145
BlackRock Resources & Commodities Strategy Trust
BCX
$899M
| $1.98M | 0.19% |
204,163
+98,605
| +93% | +$1.03M |
|
|
ETJ
146
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$563M
| $1.97M | 0.19% |
+185,133
| New | +$2.11M |
|
|
DHC
147
Diversified Healthcare Trust
DHC
$2.26B
| $1.96M | 0.19% |
89,385
+26,025
| +41% | +$570K |
|
|
OVTI
148
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $1.94M | 0.19% |
74,744
+17,971
| +32% | +$476K |
|
149
Flexsteel Industries
FLXS
$306M
| $1.92M | 0.18% |
59,472
+810
| +1% | +$26.6K |
|
|
CTCT
150
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $1.91M | 0.18% |
52,090
-64,586
| -55% | -$2.12M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2014 Portfolio in Review
As of Q4 2014, TFS Capital held 1,387 positions worth $1.05B, down 9.2% from $1.15B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
TFS Capital withdrew a net $174M in Q4 2014, closing 422 positions and reducing 349 holdings. Its most notable exit was Lattice Semiconductor, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Infinity Pharmaceuticals, Inc. worth $5.86M.
- TFS Capital's largest Q4 2014 buy was Infinity Pharmaceuticals, Inc.: 347,088 shares worth $5.86M.
- TFS Capital added most to Cambrex Corporation in Q4 2014, an estimated $4.54M increase.
- TFS Capital's biggest Q4 2014 reduction was OneSpan, cutting an estimated $7.67M.
- TFS Capital fully exited Lattice Semiconductor in Q4 2014, selling an estimated $7.09M.
- TFS Capital's ten largest holdings make up 5.7% of its $1.05B portfolio in Q4 2014.
- TFS Capital opened 364 new positions and closed 422 in Q4 2014.
- TFS Capital's portfolio value fell 9.2% quarter-over-quarter to $1.05B.
Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.